Docebo
Stock Forecast, Prediction & Price Target
Docebo (DCBO) stock Price Target by analysts
$51
Potential upside: 62.47%
Docebo price prediction
What is Docebo stock analysts` prediction?
Docebo stock forecast: Based on 3 Wall Street analysts` predicted price targets for Docebo in the last 3 months, the avarage price target is $51, with a high forecast of $NaN. The average price target represents a 62.47% change from the last price of $31.39.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Docebo stock Price Target by analysts
Full breakdown of analysts given Docebo price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Kevin Krishnaratne Scotiabank | 0% 0/2 | 11 months ago | $55 75.21% upside | $45.46 | StreetInsider | Previous targets (1) |
Kevin Kumar Goldman Sachs | 0% 0/1 | 12 months ago | $48 52.91% upside | $42.47 | StreetInsider | Previous targets (0) |
Ryan MacDonald Needham | 0% 0/2 | 12 months ago | $50 59.28% upside | $42.06 | StreetInsider | Previous targets (1) |
Robert Young Canaccord Genuity | 0% 0/2 | about 1 year ago | $54 72.02% upside | $41.74 | StreetInsider | Previous targets (1) |
George Sutton Craig-Hallum | 0% 0/1 | about 1 year ago | $58 84.77% upside | $37.22 | TheFly | Previous targets (0) |
Kevin Krishnaratne Scotiabank | 0% 0/2 | over 1 year ago | $50 59.28% upside | $36.26 | StreetInsider | Previous targets (1) |
Robert Young Canaccord Genuity | 0% 0/2 | over 1 year ago | $55 75.21% upside | $36.26 | StreetInsider | Previous targets (1) |
Ryan MacDonald Needham | 0% 0/2 | almost 2 years ago | $56 78.40% upside | $51.22 | Benzinga | Previous targets (1) |
Josh Baer Morgan Stanley | 100% 1/1 | about 2 years ago | $49 56.10% upside | $0 | StreetInsider | Previous targets (0) |
Unknown Morgan Stanley | N/A | almost 3 years ago | $36 14.68% upside | $29.8 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 3 years ago | $54 72.02% upside | $46.07 | Benzinga | N/A |
Brett Knoblauch Cantor Fitzgerald | 100% 1/1 | about 4 years ago | $82 161.22% upside | $71.87 | TipRanks | Previous targets (0) |
Docebo Financial Estimates
Docebo Revenue Estimates
Docebo EBITDA Estimates
Docebo Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $104.24M N/A | $142.91M 37.09% | $180.83M 26.53% | Avg: $251.76M Low: $233.72M High: $259.39M avg. 39.22% | Avg: $294.81M Low: $282.10M High: $299.59M avg. 17.09% | Avg: $424M Low: $405.73M High: $430.87M avg. 43.82% | Avg: $535M Low: $511.94M High: $543.67M avg. 26.17% |
Net Income
% change YoY
| $-13.60M N/A | $7.01M 151.59% | $2.84M -59.53% | Avg: $31.71M Low: $29.30M High: $38.39M avg. 1016.60% | Avg: $39.55M Low: $37.19M High: $40.23M avg. 24.74% | Avg: $56.24M Low: $53.09M High: $57.42M avg. 42.18% | Avg: $78.80M Low: $74.39M High: $80.46M avg. 40.11% |
EBITDA
% change YoY
| $-10.48M N/A | $-15.70M -49.80% | $8.43M 153.67% | Avg: $-21.35M Low: $-22.00M High: $-19.82M avg. -353.27% | Avg: $-25.00M Low: $-25.40M High: $-23.92M avg. -17.09% | Avg: $-35.96M Low: $-36.54M High: $-34.41M avg. -43.82% | Avg: $-45.37M Low: $-46.11M High: $-43.41M avg. -26.17% |
EPS
% change YoY
| -$0.41 N/A | $0.2 148.78% | $0.09 -56.35% | Avg: $0.99 Low: $0.87 High: $1.14 avg. 1029.42% | Avg: $1.17 Low: $1.1 High: $1.19 avg. 18.66% | Avg: $1.67 Low: $1.58 High: $1.71 avg. 42.73% | Avg: $2.34 Low: $2.21 High: $2.39 avg. 40.11% |
Operating Expenses
% change YoY
| $96.43M N/A | $121.66M 26.16% | $149.05M 22.51% | Avg: $172.85M Low: $160.47M High: $178.09M avg. 15.97% | Avg: $202.41M Low: $193.69M High: $205.69M avg. 17.09% | Avg: $291.11M Low: $278.56M High: $295.83M avg. 43.82% | Avg: $367.32M Low: $351.49M High: $373.28M avg. 26.17% |
FAQ
What is Docebo stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 280.91% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is 29.30M, average is 31.71M and high is 38.39M.
What is Docebo stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 31.57% in 2025-2028.
We have gathered data from 10 analysts. Their low revenue estimate is $233.72M, average is $251.76M and high is $259.39M.
What is Docebo stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 282.73% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is $0.87, average is $0.99 and high is $1.13.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering Docebo stock. The most successful analyst is Kevin Krishnaratne.